IDEAYA Biosciences Says $941.4M Of Cash, Cash Equivalents And Marketable Securities As Of March-End, Anticipated To Fund Operations Into 2028
IDEAYA Biosciences Says $941.4M Of Cash, Cash Equivalents And Marketable Securities As Of March-End, Anticipated To Fund Operations Into 2028
IDEAYA Biosciences表示，截至3月底，有9.414亿美元的现金、现金等价物和有价证券，预计将为2028年的运营提供资金
IDEAYA Biosciences Says $941.4M Of Cash, Cash Equivalents And Marketable Securities As Of March-End, Anticipated To Fund Operations Into 2028
IDEAYA Biosciences表示，截至3月底，有9.414亿美元的现金、现金等价物和有价证券，预计将为2028年的运营提供资金
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。